Johnson Health Tech .Co., Ltd.

TWSE:1736.TW

119 (TWD) • At close September 16, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) TWD.

202320222021202020192018201720162015201420132012201120102009200820072006
Revenue 38,069.56333,612.94730,779.32828,366.75625,372.56121,757.06419,494.43120,164.51516,974.9316,551.03615,071.15415,320.8913,634.14411,749.60810,089.36512,051.44411,809.1411,321.209
Cost of Revenue 20,800.13819,006.57616,873.07214,969.26912,825.69411,719.86810,289.95410,828.8899,153.7238,906.298,473.7418,145.6067,447.5726,447.2665,408.0376,640.2116,526.2835,782.999
Gross Profit 17,269.42514,606.37113,906.25613,397.48712,546.86710,037.1969,204.4779,335.6267,821.2077,644.7466,597.4137,175.2846,186.5725,302.3424,681.3285,411.2335,282.8575,538.21
Gross Profit Ratio 0.4540.4350.4520.4720.4950.4610.4720.4630.4610.4620.4380.4680.4540.4510.4640.4490.4470.489
Reseach & Development Expenses 1,061.934913.224808.652785.536650.646476.643460.776484.345445.348392.79402.869375.603370.035334.925276.915463.153401.614282.759
General & Administrative Expenses 7,630.2477,075.2836,141.8355,443.7335,721.0165,291.2034,975.1684,142.913,634.6422,990.8932,688.5872,872.9152,297.2472,252.5351,829.2481,649.4391,714.7211,182.222
Selling & Marketing Expenses 8,355.5466,814.3946,417.3376,186.5314,467.0184,217.7053,631.8414,091.7633,081.192,919.4352,795.0652,999.52,624.2672,236.6612,548.4653,302.4872,725.7032,198.66
SG&A 14,965.17613,889.67712,559.17211,630.26410,188.0349,508.9088,607.0098,234.6736,715.8325,910.3285,483.6525,872.4154,921.5144,489.1964,377.7134,951.9264,440.4243,380.882
Other Expenses 275.451609.54820.58128.03200.401374.879225.519501.057291.6352,025.102296.96865.97351.04452.594-97.33630.346-8.80940.184
Operating Expenses 16,027.1114,802.90113,367.82412,415.810,838.689,985.5519,067.7858,719.0187,161.186,303.1185,886.5216,248.0185,291.5494,824.1214,654.6285,415.0794,842.0383,663.641
Operating Income 1,242.315578.19711.4261,190.1581,908.58851.645136.692616.608660.0271,341.628710.892927.266895.023478.22126.7-3.846440.8191,874.569
Operating Income Ratio 0.0330.0170.0230.0420.0750.0020.0070.0310.0390.0810.0470.0610.0660.0410.003-00.0370.166
Total Other Income Expenses Net 92.167-274.584-547.726-214.826-291.386241.2188.305385.799208.961,935.614211.359100.3236.613-150.405-78.925-48.196124.04366.158
Income Before Tax 1,334.482303.606163.7975.3321,617.202292.855224.9971,002.407868.9873,277.242922.2511,027.586931.636327.816-52.225-52.042564.8621,940.727
Income Before Tax Ratio 0.0350.0090.0050.0340.0640.0130.0120.050.0510.1980.0610.0670.0680.028-0.005-0.0040.0480.171
Income Tax Expense 625.04578.66564.331227.978323.181-97.46794.395285.988304.907639.59765.311169.829161.02380.38420.00310.54576.874222.073
Net Income 709.828224.94199.369679.2931,292.531389.787130.176716.18563.6052,637.7856.968857.357770.689250.686-65.5262.259560.2661,706.627
Net Income Ratio 0.0190.0070.0030.0240.0510.0180.0070.0360.0330.1590.0570.0560.0570.021-0.00600.0470.151
EPS 2.340.740.332.244.261.290.432.361.858.682.832.832.540.83-0.220.0061.855.64
EPS Diluted 2.340.740.332.244.261.290.432.361.858.682.832.832.540.83-0.220.0061.855.64
EBITDA 2,640.3141,784.771,751.6512,174.1652,785.122822.47711.1141,454.4661,293.593,739.9041,410.2111,563.0931,499.758909.004556.76520.7771,083.7462,337.829
EBITDA Ratio 0.0690.0530.0570.0770.110.0380.0360.0720.0760.2260.0940.1020.110.0770.0550.0430.0920.206